REDWOOD CITY, Calif. / May 07, 2024 / Business Wire / Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in two upcoming investor conferences: BofA Securities Health Care Conference 2024 (In Person) Presentation: Tuesday, May 14 at 3:40 p.m.... Read More